Celsion Corp
Change company Symbol lookup
Select an option...
CLSN Celsion Corp
CVX Chevron Corp
VTVT vTv Therapeutics Inc
BUGDF Bumrungrad Hospital PCL
ORCL Oracle Corp
OPTT Ocean Power Technologies Inc
SPEYF Spey Resources Corp
BCTX Briacell Therapeutics Corp
JAZZ Jazz Pharmaceuticals PLC
KRT Karat Packaging Inc
Go

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Health Care : Biotechnology | Small Cap Value
Company profile

Celsion Corporation is an oncology drug development company. The Company's product candidate is ThermoDox, a heat-activated liposomal encapsulation of doxorubicin, which is in Phase III clinical trial for treatment of primary liver cancer (the OPTIMA Study) and a Phase II clinical trial for treatment of recurrent chest wall breast cancer (the DIGNITY Study). Its pipeline also includes GEN-1, a deoxyribonucleic acid (DNA) mediated immunotherapy for the localized treatment of ovarian and brain cancers. It has over three platform technologies for the development of treatments for those suffering with difficult-to-treat forms of cancer, including Lysolipid Thermally Sensitive Liposomes, a heat sensitive liposomal based dosage form that targets disease with known therapeutics in the presence of mild heat; TheraPlas, a nucleic acid-based treatment for local transfection of therapeutic plasmids, and TheraSilence, a systemic dosage form for lung directed anti-cancer ribonucleic acid (RNA).

Price
Delayed
$1.20
Day's Change
-0.01 (-0.83%)
Bid
--
Ask
--
B/A Size
--
Day's High
1.22
Day's Low
1.17
Volume
(Light)

Today's volume of 485,953 shares is on pace to be much lighter than CLSN's 10-day average volume of 2,901,624 shares.

485,953
  • Prev Close
    1.21
  • Today's Open
    1.21
  • Day's Range
    1.17-1.22
  • Avg Vol (10-day)
    2.9M
  • Last (time)
    10:51a ET 06/22/21
  • Last (size)
    100
  • 52-Wk Range
    0.4305 - 5.24
    LowHigh
  • (06/22/20 - 11/02/20)
    178.75%
  • 158.7%
  • Market Cap
    103.9M
  • Shares Outstanding
    86.6M
  • -0.58
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 1.9
  • 16.25
  • (% of float 05/28/21)
    2.05

Latest News

June 21, 2021
8:00 am ET
Globe Newswire
June 09, 2021
8:00 am ET
Globe Newswire
June 08, 2021
8:00 am ET
Globe Newswire
June 07, 2021
5:00 pm ET
Globe Newswire
June 04, 2021
10:11 am ET
Globe Newswire
June 02, 2021
9:27 am ET
Globe Newswire
May 27, 2021
8:30 am ET
Globe Newswire
May 14, 2021
8:16 am ET
Accesswire
8:00 am ET
Globe Newswire
May 11, 2021
8:00 am ET
Globe Newswire
May 07, 2021
8:30 am ET
Globe Newswire
May 06, 2021
9:31 am ET
PR Newswire
April 22, 2021
8:30 am ET
Globe Newswire
April 05, 2021
5:00 pm ET
Globe Newswire
April 01, 2021
8:30 am ET
Globe Newswire
March 31, 2021
8:00 am ET
Globe Newswire
January 21, 2021
10:01 pm ET
MarketWatch
8:47 am ET
MarketWatch
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.